These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended
March 31, 2016
.
|
|
¨
|
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
Delaware
(State or Other Jurisdiction of
Incorporation or Organization) |
77-0312442
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
|
Non-accelerated filer
o
|
Smaller reporting company
x
|
|
PART I - FINANCIAL INFORMATION
|
|
|
|
Item 1. Financial Statements
|
||
|
|
Condensed Consolidated Balance Sheets at March 31, 2016 (unaudited) and December 31, 2015
|
|
|
|
Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2016 and 2015
|
|
|
|
Unaudited Condensed Consolidated Statement of Stockholders’ Equity for the three months ended March 31, 2016
|
|
|
|
Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2016 and 2015
|
|
|
|
Notes to unaudited Condensed Consolidated Financial Statements
|
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
||
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
||
|
Item 4. Controls and Procedures
|
||
|
|
|
|
|
PART II - OTHER INFORMATION
|
|
|
|
Item 1. Legal Proceedings
|
||
|
Item 1A. Risk Factors
|
||
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
||
|
Item 3. Defaults Upon Senior Securities
|
||
|
Item 4. Mine Safety Disclosures
|
||
|
Item 5. Other Information
|
||
|
Item 6. Exhibits
|
||
|
Signatures
|
||
|
|
March 31,
2016 |
|
December 31, 2015
|
||||
|
|
(Unaudited)
|
|
|
||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash
|
$
|
2,031
|
|
|
$
|
1,764
|
|
|
Accounts receivable, net
|
2,743
|
|
|
2,698
|
|
||
|
Prepaid expenses and other current assets
|
518
|
|
|
553
|
|
||
|
Total current assets
|
5,292
|
|
|
5,015
|
|
||
|
Property and equipment, net
|
2,735
|
|
|
2,986
|
|
||
|
Goodwill
|
9,825
|
|
|
9,825
|
|
||
|
Intangibles, net
|
1,961
|
|
|
2,178
|
|
||
|
Other assets
|
13
|
|
|
30
|
|
||
|
Total assets
|
$
|
19,826
|
|
|
$
|
20,034
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Current portion of long-term debt
|
$
|
400
|
|
|
$
|
400
|
|
|
Accounts payable
|
423
|
|
|
385
|
|
||
|
Accrued expenses and other liabilities
|
1,414
|
|
|
1,492
|
|
||
|
Accrued dividends
|
39
|
|
|
36
|
|
||
|
Accrued sales taxes and regulatory fees
|
649
|
|
|
441
|
|
||
|
Total current liabilities
|
2,925
|
|
|
2,754
|
|
||
|
Long term liabilities:
|
|
|
|
||||
|
Deferred tax liability
|
346
|
|
|
309
|
|
||
|
Long term debt, net of current portion
|
10,606
|
|
|
10,588
|
|
||
|
Total long term liabilities
|
10,952
|
|
|
10,897
|
|
||
|
Total liabilities
|
13,877
|
|
|
13,651
|
|
||
|
Commitments and contingencies (see Note 10)
|
|
|
|
|
|
||
|
Stockholders’ equity:
|
|
|
|
||||
|
Preferred stock, Series A-2, convertible; $.0001 par value; $7,500 stated value; 7,500 shares authorized, 32 shares issued and outstanding and liquidation preference of $237 at March 31, 2016 and December 31, 2015
|
100
|
|
|
100
|
|
||
|
Common stock, $.0001 par value; 150,000,000 shares authorized; 36,059,000 issued and 35,855,000 outstanding at March 31, 2016 and 35,889,000 issued and 35,710,000 outstanding at December 31, 2015
|
4
|
|
|
4
|
|
||
|
Treasury stock, 204,000 and 179,000 shares at March 31, 2016 and December 31, 2015, respectively
|
(219
|
)
|
|
(206
|
)
|
||
|
Additional paid-in capital
|
179,533
|
|
|
179,242
|
|
||
|
Accumulated deficit
|
(173,469
|
)
|
|
(172,757
|
)
|
||
|
Total stockholders’ equity
|
5,949
|
|
|
6,383
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
19,826
|
|
|
$
|
20,034
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Revenue
|
$
|
5,518
|
|
|
$
|
7,163
|
|
|
Operating expenses:
|
|
|
|
||||
|
Cost of revenue (exclusive of depreciation and amortization)
|
3,459
|
|
|
3,949
|
|
||
|
Research and development
|
287
|
|
|
298
|
|
||
|
Sales and marketing
|
280
|
|
|
708
|
|
||
|
General and administrative
|
1,240
|
|
|
1,403
|
|
||
|
Impairment charges
|
—
|
|
|
125
|
|
||
|
Depreciation and amortization
|
547
|
|
|
555
|
|
||
|
Total operating expenses
|
5,813
|
|
|
7,038
|
|
||
|
Income (loss) from operations
|
(295
|
)
|
|
125
|
|
||
|
Interest and other expense, net
|
380
|
|
|
359
|
|
||
|
Loss before income taxes
|
(675
|
)
|
|
(234
|
)
|
||
|
Income tax expense
|
37
|
|
|
—
|
|
||
|
Net loss
|
(712
|
)
|
|
(234
|
)
|
||
|
Preferred stock dividends
|
3
|
|
|
5
|
|
||
|
Net loss attributable to common stockholders
|
$
|
(715
|
)
|
|
$
|
(239
|
)
|
|
|
|
|
|
||||
|
Net loss attributable to common stockholders per share:
|
|
|
|
||||
|
Basic and diluted net loss per share
|
$
|
(0.02
|
)
|
|
$
|
(0.01
|
)
|
|
|
|
|
|
||||
|
Weighted average number of shares of common stock:
|
|
|
|
||||
|
Basic and diluted
|
35,456
|
|
|
35,482
|
|
||
|
|
Series A-2 Preferred Stock
|
|
Common Stock
|
|
Treasury Stock
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Additional Paid-In Capital
|
|
Accumulated Deficit
|
|
Total
|
|||||||||||||||
|
Balance at December 31, 2015
|
32
|
|
|
$
|
100
|
|
|
35,889
|
|
|
$
|
4
|
|
|
179
|
|
|
$
|
(206
|
)
|
|
$
|
179,242
|
|
|
$
|
(172,757
|
)
|
|
$
|
6,383
|
|
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(712
|
)
|
|
(712
|
)
|
||||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
312
|
|
|
—
|
|
|
312
|
|
||||||
|
2014 Plan equity issuance costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(18
|
)
|
|
—
|
|
|
(18
|
)
|
||||||
|
Issuance of restricted stock
|
—
|
|
|
—
|
|
|
170
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Preferred stock dividends
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
|
(3
|
)
|
||||||
|
Repurchase of common stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
25
|
|
|
(13
|
)
|
|
—
|
|
|
—
|
|
|
(13
|
)
|
||||||
|
Balance at March 31, 2016
|
32
|
|
|
$
|
100
|
|
|
36,059
|
|
|
$
|
4
|
|
|
204
|
|
|
$
|
(219
|
)
|
|
$
|
179,533
|
|
|
$
|
(173,469
|
)
|
|
$
|
5,949
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net loss
|
$
|
(712
|
)
|
|
$
|
(234
|
)
|
|
Adjustments to reconcile net loss to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
547
|
|
|
555
|
|
||
|
Bad debt recovery
|
(9
|
)
|
|
(3
|
)
|
||
|
Amortization of deferred financing costs
|
18
|
|
|
22
|
|
||
|
Stock-based compensation expense
|
312
|
|
|
113
|
|
||
|
Impairment charges
|
—
|
|
|
125
|
|
||
|
Deferred tax provision
|
37
|
|
|
—
|
|
||
|
Increase (decrease) attributable to changes in assets and liabilities:
|
|
|
|
||||
|
Accounts receivable
|
(36
|
)
|
|
(281
|
)
|
||
|
Prepaid expenses and other current assets
|
34
|
|
|
187
|
|
||
|
Other assets
|
—
|
|
|
28
|
|
||
|
Accounts payable
|
38
|
|
|
206
|
|
||
|
Accrued expenses and other liabilities
|
129
|
|
|
(116
|
)
|
||
|
Net cash provided by operating activities
|
358
|
|
|
602
|
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Purchases of property and equipment
|
(78
|
)
|
|
(533
|
)
|
||
|
Proceeds from sale of equipment
|
—
|
|
|
3
|
|
||
|
Net cash used in investing activities
|
(78
|
)
|
|
(530
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Principal payments for capital lease obligations
|
—
|
|
|
(18
|
)
|
||
|
Proceeds from issuance of common stock
|
—
|
|
|
18
|
|
||
|
Purchase of treasury stock
|
(13
|
)
|
|
(139
|
)
|
||
|
Net cash used in financing activities
|
(13
|
)
|
|
(139
|
)
|
||
|
Increase (decrease) in cash and cash equivalents
|
267
|
|
|
(67
|
)
|
||
|
Cash at beginning of period
|
1,764
|
|
|
1,938
|
|
||
|
Cash at end of period
|
$
|
2,031
|
|
|
$
|
1,871
|
|
|
|
|
|
|
||||
|
Supplement disclosures of cash flow information:
|
|
|
|
||||
|
Cash paid during the period for interest
|
$
|
281
|
|
|
$
|
355
|
|
|
|
|
|
|
||||
|
Non-cash investing and financing activities:
|
|
|
|
||||
|
Preferred stock dividends
|
$
|
3
|
|
|
$
|
5
|
|
|
Accrued capital expenditure
|
$
|
—
|
|
|
$
|
48
|
|
|
Recognition of prepaid equity issuance costs as additional paid-in capital
|
$
|
—
|
|
|
$
|
134
|
|
|
|
March 31, 2016
|
|
December 31, 2015
|
||||
|
Accrued compensation
|
$
|
242
|
|
|
$
|
247
|
|
|
Accrued communication costs
|
137
|
|
|
180
|
|
||
|
Accrued professional fees
|
98
|
|
|
133
|
|
||
|
Accrued interest
|
411
|
|
|
332
|
|
||
|
Other accrued expenses
|
171
|
|
|
227
|
|
||
|
Deferred rent expense
|
85
|
|
|
89
|
|
||
|
Deferred revenue
|
91
|
|
|
105
|
|
||
|
Customer deposits
|
179
|
|
|
179
|
|
||
|
Accrued expenses and other liabilities
|
$
|
1,414
|
|
|
$
|
1,492
|
|
|
|
March 31, 2016
|
|
December 31, 2015
|
||||
|
Main Street Term Loan, net of unamortized debt discount based on an imputed interest rate of 12%; $179 at March 31, 2016 and $197 at December 31, 2015, respectively.
|
$
|
8,821
|
|
|
$
|
8,803
|
|
|
Main Street Revolver
|
400
|
|
|
400
|
|
||
|
SRS Note
|
1,785
|
|
|
1,785
|
|
||
|
|
11,006
|
|
|
10,988
|
|
||
|
Less current maturities
|
(400
|
)
|
|
(400
|
)
|
||
|
Long-term debt, net of current portion
|
$
|
10,606
|
|
|
$
|
10,588
|
|
|
|
Outstanding
|
|
Exercisable
|
||||||||||
|
|
Number of Shares Underlying Options
|
|
Weighted
Average Exercise Price |
|
Number of Shares Underlying Options
|
|
Weighted
Average Exercise Price |
||||||
|
Options outstanding, December 31, 2015
|
1,269
|
|
|
$
|
1.98
|
|
|
960
|
|
|
$
|
1.99
|
|
|
Granted
|
—
|
|
|
—
|
|
|
|
|
|
||||
|
Exercised
|
—
|
|
|
—
|
|
|
|
|
|
||||
|
Expired
|
—
|
|
|
—
|
|
|
|
|
|
||||
|
Forfeited and canceled
|
(19
|
)
|
|
1.71
|
|
|
|
|
|
||||
|
Options outstanding, March 31, 2016
|
1,250
|
|
|
$
|
1.99
|
|
|
1,026
|
|
|
$
|
2.02
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
General and administrative
|
$
|
94
|
|
|
$
|
102
|
|
|
|
$
|
94
|
|
|
$
|
102
|
|
|
|
Restricted Shares
|
|
Weighted Average
Grant Price |
|||
|
Unvested restricted shares outstanding, December 31, 2015
|
261
|
|
|
$
|
1.58
|
|
|
Granted
|
170
|
|
|
0.55
|
|
|
|
Vested
|
(68
|
)
|
|
1.67
|
|
|
|
Forfeited
|
—
|
|
|
—
|
|
|
|
Unvested restricted shares outstanding, March 31, 2016
|
363
|
|
|
$
|
1.08
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Cost of revenue
|
$
|
2
|
|
|
$
|
(22
|
)
|
|
Research and development
|
1
|
|
|
(5
|
)
|
||
|
Sales and marketing
|
—
|
|
|
(31
|
)
|
||
|
General and administrative
|
117
|
|
|
(1
|
)
|
||
|
|
$
|
120
|
|
|
$
|
(59
|
)
|
|
|
Restricted Stock Units
|
|
Weighted Average
Grant Price |
|||
|
Unvested restricted stock units outstanding, December 31, 2015
|
2,164
|
|
|
$
|
1.02
|
|
|
Granted
|
1,206
|
|
|
0.55
|
|
|
|
Vested
|
(187
|
)
|
|
1.05
|
|
|
|
Forfeited
|
(38
|
)
|
|
0.98
|
|
|
|
Unvested restricted stock units outstanding, March 31, 2016
|
3,145
|
|
|
$
|
0.84
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Cost of revenue
|
$
|
8
|
|
|
$
|
2
|
|
|
Research and development
|
9
|
|
|
2
|
|
||
|
Sales and marketing
|
4
|
|
|
1
|
|
||
|
General and administrative
|
77
|
|
|
65
|
|
||
|
|
$
|
98
|
|
|
$
|
70
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Net loss
|
$
|
(712
|
)
|
|
$
|
(234
|
)
|
|
Less: preferred stock dividends
|
3
|
|
|
5
|
|
||
|
Net loss attributable to common stockholders
|
$
|
(715
|
)
|
|
$
|
(239
|
)
|
|
|
|
|
|
||||
|
Weighted average shares outstanding - basic
|
35,456
|
|
|
35,482
|
|
||
|
Weighted average shares outstanding - diluted
|
35,456
|
|
|
35,482
|
|
||
|
Basic and diluted net loss per share
|
$
|
(0.02
|
)
|
|
$
|
(0.01
|
)
|
|
Year Ending December 31,
|
|
||
|
Remaining 2016
|
$
|
220
|
|
|
2017
|
301
|
|
|
|
2018
|
308
|
|
|
|
2019
|
88
|
|
|
|
2020
|
23
|
|
|
|
|
$
|
940
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Revenue
|
|
|
|
||||
|
Video collaboration services
|
$
|
2,988
|
|
|
$
|
4,280
|
|
|
Network services
|
2,347
|
|
|
2,727
|
|
||
|
Professional and other services
|
183
|
|
|
156
|
|
||
|
Total revenue
|
$
|
5,518
|
|
|
$
|
7,163
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Net loss
|
$
|
(712
|
)
|
|
$
|
(234
|
)
|
|
Depreciation and amortization
|
547
|
|
|
555
|
|
||
|
Interest and other expense, net
|
380
|
|
|
359
|
|
||
|
Income tax expense
|
37
|
|
|
—
|
|
||
|
EBITDA
|
252
|
|
|
680
|
|
||
|
Stock-based compensation
|
312
|
|
|
113
|
|
||
|
Severance
|
57
|
|
|
53
|
|
||
|
Impairment charges
|
—
|
|
|
125
|
|
||
|
Adjusted EBITDA
|
$
|
621
|
|
|
$
|
971
|
|
|
Exhibit
Number
|
|
Description
|
|
10.1
|
|
Amended and Restated Employment Agreement between Glowpoint, Inc. and Peter Holst, dated as of January 28, 2016 (filed as Exhibit 10.1 to Registrant’s Current Report on Form 8-K filed with the SEC on January 29, 2016, and incorporated herein by reference).
|
|
10.2
|
|
First Amendment to Employment Agreement between Glowpoint, Inc. and David Clark, dated as of January 28, 2016 (filed as Exhibit 10.2 to Registrant’s Current Report on Form 8-K filed with the SEC on January 29, 2016, and incorporated herein by reference).
|
|
31.1*
|
|
Rule 13a—14(a)/15d—14(a) Certification of the Chief Executive Officer.
|
|
31.2*
|
|
Rule 13a—14(a)/15d—14(a) Certification of the Chief Financial Officer.
|
|
32.1*
|
|
Section 1350 Certification of the Chief Executive Officer and Chief Financial Officer.
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
GLOWPOINT, INC.
|
|
|
|
|
|
|
5/9/2016
|
By:
|
/s/ Peter Holst
|
|
|
|
Peter Holst
|
|
|
|
Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
5/9/2016
|
By:
|
/s/ David Clark
|
|
|
|
David Clark
|
|
|
|
Chief Financial Officer
|
|
|
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|